IQVIA Holdings Inc.
IQV
Classifica tra le azioni
#560
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Prezzo delle azioni
$266.90
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$43.93B
Variazione (1 giorno)
-1.32%
Variazione (1 anno)
30.48%
Paese
US
Scambia IQVIA Holdings Inc. (IQV)
Categoria
Healthcare
Margine operativo per IQVIA Holdings Inc. (IQV)
Margine operativo al October 2026 TTM: 13.57%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di IQVIA Holdings Inc., il margine operativo attuale (TTM) è 13.57%. Alla fine del 2024, il margine operativo era 14.29%.
Storico del margine operativo per IQVIA Holdings Inc. da 2010 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 13.57% | -3.21% |
| 2025 | 14.02% | -1.89% |
| 2024 | 14.29% | 8.34% |
| 2023 | 13.19% | 5.69% |
| 2022 | 12.48% | 24.30% |
| 2021 | 10.04% | 55.90% |
| 2020 | 6.44% | -8.13% |
| 2019 | 7.01% | -1.54% |
| 2018 | 7.12% | -3.91% |
| 2017 | 7.41% | -21.34% |
| 2016 | 9.42% | -16.42% |
| 2015 | 11.27% | 4.26% |
| 2014 | 10.81% | 19.18% |
| 2013 | 9.07% | 11.29% |
| 2012 | 8.15% | 2.13% |
| 2011 | 7.98% | -20.75% |
| 2010 | 10.07% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 17.97% | -98.68% |
US
|
|
| 20.42% | -98.50% |
US
|
|
| -10.70% | -100.79% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.36% |
US
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.